Postoperative Ketorolac in Breast and Body Contouring Procedures: A Nationwide Claims Analysis.

ABSTRACT:

Background

Nonsteroidal antiinflammatory drugs are useful alternatives to narcotics for analgesia. However, concerns remain regarding their safety. The authors evaluated ketorolac use and complications. We hypothesized that no association between ketorolac and morbidity exists in patients undergoing body contouring.

Methods

Truven MarketScan claims database was analyzed for patients undergoing breast and body contouring surgery. Patients selected received ketorolac and were enrolled a minimum of 90 days. The authors performed a multivariable logistic regression to calculate risk of morbidity, adjusting for clinical and sociodemographic factors.

Results

Among the 106,279 patients enrolled, 4924 (4.6 percent) received postoperative ketorolac. In multivariable regression

SUBMITTER: Kelley BP 

PROVIDER: S-EPMC6159224 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature